Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 242
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05504187 Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in… |
KP104 | Lupus | Phase 2 | WITHDRAWN | En attente / non publié | Kira Pharmacenticals (US), LLC. | Non communiqué | 2025-03 → 2027-04 | Ouvrir |
| NCT05796206 A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus |
MIL62 | Lupus | Phase 2 | COMPLETED | En attente / non publié | Beijing Mabworks Biotech Co., Ltd. | China · Peking University People's Hospital, Beijing,… | 2023-05-26 → 2026-07-02 | Ouvrir |
| NCT07913919 AISLE — Effect of Anifrolumab on Arterial Inflammation in Systemic Lupu… |
Anifrolumab | Lupus | Non applicable | RECRUITING | En attente / non publié | University of Cambridge | United Kingdom · Addenbrookes Hospital, Cambridge, Un… | 2025-11-28 → 2027-11-01 | Ouvrir |
| NCT07260877 AERIS — A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ph… |
VENT-03 | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Ventus Therapeutics U.S., Inc. | United States, Bulgaria, France, Georgia, Hungary, Po… | 2025-12-03 → 2027-03 | Ouvrir |
| NCT07323524 Dapa-Active LN — Dapagliflozin in Active Lupus Nephritis |
Dapagliflozin (10Mg Tab) along wi… | Lupus | Phase 4 | RECRUITING | En attente / non publié | Brigham and Women's Hospital | United States · Brigham and Women's Hospital, Boston,… | 2026-05-22 → 2028-09-01 | Ouvrir |
| NCT07923747 An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthr… |
DKB903 | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Non communiqué | 2026-12-01 → 2029-02-21 | Ouvrir |
| NCT07901764 MYTP01 for Immune-Mediated Diseases |
MYTP01 | Lupus | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Zhejiang Provincial People's Hosp… | China · Zhejiang Provincial People's Hospital, Hangzh… | 2026-12 → 2028-12 | Ouvrir |
| NCT07649265 A Trial in Healthy Adult Participants and Adults With Autoimmune Diseas… |
HBM7020 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Otsuka Pharmaceutical Development… | Australia · Q-Pharm Pty Ltd, Brisbane, Australia | 2026-09-24 → 2028-11-20 | Ouvrir |
| NCT07829497 Pain Phenotyping of Rheumatic Diseases - An Observational Study |
Bedside quantitative sensory test… | Lupus | À vérifier | RECRUITING | En attente / non publié | National Institute of Arthritis a… | United States · National Institutes of Health Clinica… | 2026-11-16 → 2036-06-15 | Ouvrir |
| NCT07355218 A Study of Enpatoran in Participants With Cutaneous Manifestations of L… |
Enpatoran | Lupus | Phase 3 | RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, Australia, Belgium, Brazil, Bulgaria, … | 2026-04-01 → 2029-05-25 | Ouvrir |
| NCT07332481 ELOWEN-1 — A Study of Enpatoran in Participants With Cutaneous Manifest… |
Enpatoran | Lupus | Phase 3 | RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, Australia, Belgium, Brazil, Bulgaria, … | 2026-03-10 → 2029-05-24 | Ouvrir |
| NCT07438496 GARDENIA-SLE — A Study of Nipocalimab in Adults With Moderate to Severe… |
Nipocalimab | Lupus | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Argentina, Australia, Brazil, Bulgaria… | 2026-03-05 → 2031-11-07 | Ouvrir |
| NCT07629583 To Evaluate the Effects of Cevostamab in Participants With Systemic Lup… |
Cevostamab | Lupus | Phase 1 | RECRUITING | En attente / non publié | Genentech, Inc. | Australia, Brazil, China, France, Italy, Spain · Fund… | 2026-11-02 → 2030-03-29 | Ouvrir |
| NCT06265220 AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed … |
AB-101 | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Artiva Biotherapeutics, Inc. | United States · Artiva Investigational Site Aventura,… | 2024-04-03 → 2027-08 | Ouvrir |
| NCT05559671 Safety of the Herpes Zoster Subunit Vaccine in Lupus |
Herpes Zoster Subunit (HZ/su) Vac… | Lupus | Phase 4 | RECRUITING | En attente / non publié | NYU Langone Health | United States · NYU Langone Health, New York, United … | 2023-12-21 → 2028-02-01 | Ouvrir |
| NCT06411249 A Study Describing the Efficacy and Safety of Belimumab Administered in… |
Belimumab (GSK1550188) | Lupus | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | GlaxoSmithKline | United States, Argentina, Brazil, France, Germany, Gr… | 2024-06-06 → 2029-07-30 | Ouvrir |
| NCT07732309 ATTRACT — A Study of ATG-201 in Adult Participants With Autoimmune Dise… |
ATG-201 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Antengene Biologics Limited | China · Huashan Hospital affiliated to Fudan Universi… | 2026-09-26 → 2029-06-01 | Ouvrir |
| NCT07659704 CLEVER-SLE — CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lu… |
Autologous CD19-Directed CAR-T Ce… | Lupus | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | University of Sao Paulo | Brazil · Hospital das Clínicas da Faculdade de Medici… | 2026-10-01 → 2028-10-01 | Ouvrir |
| NCT07906145 A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Di… |
QLS2416 Injection | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Shanghai Qilu Pharmaceutical Rese… | Non communiqué | 2026-12 → 2029-12 | Ouvrir |
| NCT07881120 DISCOVERY — Study of Afimetoran in Adults With Cutaneous Lupus Erythema… |
Afimetoran | Lupus | Phase 2/3 | RECRUITING | En attente / non publié | Beeline Medicines Corporation | United States · Boeson Research MSO, Missoula, United… | 2026-10 → 2031-04 | Ouvrir |
| NCT06462144 IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, a… |
IMPT-514 CART Cell Injection | SEP | Phase 1 | TERMINATED | En attente / non publié | The Affiliated Nanjing Drum Tower… | China · The Affiliated Hospital of Xuzhou Medical Uni… | 2024-06-13 → 2025-10-21 | Ouvrir |
| NCT07491900 A Phase 1 Study of HB2198 in Participants With Moderately to Severely A… |
HB2198 | SEP | Phase 1 | RECRUITING | En attente / non publié | Hinge Bio | Australia · Investigational site, Brisbane, Australia | 2026-03-23 → 2028-10-24 | Ouvrir |
| NCT06925542 A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Re… |
CTX112 | Myopathies | Phase 1 | RECRUITING | En attente / non publié | CRISPR Therapeutics | United States, Germany, Spain · Boston Medical Center… | 2025-03-10 → 2031-12-31 | Ouvrir |
| NCT07413341 in vivo CAR-T — A Clinical Study of TI-0032-III Injection in Patients W… |
TI-0032-III injection | Lupus | Phase 1 | RECRUITING | En attente / non publié | Therorna | China · Shanghai ChangZheng hospital, Shanghai, China | 2026-01-22 → 2027-05-30 | Ouvrir |
| NCT05732402 RUBY-3 — An Open-label Study of Povetacicept in Autoantibody-Associated… |
Povetacicept | Lupus | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Vertex Pharmaceuticals Incorporat… | United States, Australia, Puerto Rico, South Korea · … | 2023-03-15 → 2028-03-02 | Ouvrir |